A Bitcoin Treasury Company Has a Doctor on Staff, But Why?
Nakamoto Inc. (NAKA) defended its Chief Medical Officer role, saying it stems from its 2025 reverse merger with KindlyMD, a Utah pain-management company, and that maintaining the healthcare business is tied to Nasdaq listing requirements. Analysts cited NAKA’s Q1 2026 10-Q showing a $238 million net loss and $2.3 million operating revenue, plus $7.3 million insider compensation, amid 58% dilution and a 1-for-40 reverse split.